List of GenVec patents

Patents where

Current Assignee

Name

GenVec

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11279951 Adenoviral vector encoding human atonal homolog-1 (HATH1)	Patent 11279951 was granted and assigned to GenVec on March, 2022 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	11279951	March 22, 2022
‌ US Patent 7214368 Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene	Patent 7214368 was granted and assigned to GenVec on May, 2007 by the United States Patent and Trademark Office.		GenVec	United States Patent and Trademark Office	7214368	May 8, 2007
‌ US Patent 9617560 Simian (gorilla) adenovirus or adenoviral vectors and methods of use	Patent 9617560 was granted and assigned to GenVec on April, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9617560	April 11, 2017
‌ US Patent 11359214 Simian (gorilla) adenovirus or adenoviral vectors and methods of use		GenVec	GenVec	United States Patent and Trademark Office	11359214	June 14, 2022
‌ US Patent 7195896 Complementary adenoviral vector systems and cell lines	Patent 7195896 was granted and assigned to GenVec on March, 2007 by the United States Patent and Trademark Office.		GenVec	United States Patent and Trademark Office	7195896	March 27, 2007
‌ US Patent 9586998 Methods of propagating monkey adenoviral vectors	Patent 9586998 was granted and assigned to GenVec on March, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9586998	March 7, 2017
‌ US Patent 11034975 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 11034975 was granted and assigned to GenVec on June, 2021 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	11034975	June 15, 2021
‌ US Patent 9629906 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 9629906 was granted and assigned to GenVec on April, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9629906	April 25, 2017
‌ US Patent 9580476 Adenoviral vector-based respiratory syncytial virus (RSV) vaccine	Patent 9580476 was granted and assigned to GenVec on February, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9580476	February 28, 2017
‌ US Patent 10272162 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 10272162 was granted and assigned to GenVec on April, 2019 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	10272162	April 30, 2019
‌ US Patent 9388429 Method for propagating adenoviral vectors encoding inhibitory gene products	Patent 9388429 was granted and assigned to GenVec on July, 2016 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9388429	July 12, 2016
‌ US Patent 9833502 Malaria antigens and methods of use	Patent 9833502 was granted and assigned to GenVec on December, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9833502	December 5, 2017
‌ US Patent 9233153 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 9233153 was granted and assigned to GenVec on January, 2016 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9233153	January 12, 2016
‌ US Patent 10260074 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 10260074 was granted and assigned to GenVec on April, 2019 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	10260074	April 16, 2019
‌ US Patent 10059962 Simian (gorilla) adenovirus or adenoviral vectors and methods of use	Patent 10059962 was granted and assigned to GenVec on August, 2018 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	10059962	August 28, 2018
‌ US Patent 9790519 Modified serotype 28 adenoviral vectors	Patent 9790519 was granted and assigned to GenVec on October, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9790519	October 17, 2017
‌ US Patent 10022432 Malaria antigens and methods of use	Patent 10022432 was granted and assigned to GenVec on July, 2018 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	10022432	July 17, 2018
‌ US Patent 9725738 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 9725738 was granted and assigned to GenVec on August, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9725738	August 8, 2017
‌ US Patent 9951351 Adenoviral vector encoding human atonal homolog-1 (HATH1)	Patent 9951351 was granted and assigned to GenVec on April, 2018 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9951351	April 24, 2018
‌ US Patent 10792376 Affenadenovirus (gorilla) or adenoviral vectors and methods of use	Patent 10792376 was granted and assigned to GenVec on October, 2020 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	10792376	October 6, 2020
‌ US Patent 10787682 Simian (gorilla) adenovirus or adenoviral vectors and methods of use		GenVec	GenVec	United States Patent and Trademark Office	10787682	September 29, 2020
‌ US Patent 9676824 Herpes simplex virus vaccine	Patent 9676824 was granted and assigned to GenVec on June, 2017 by the United States Patent and Trademark Office.	GenVec	GenVec	United States Patent and Trademark Office	9676824	June 13, 2017
‌ US Patent 7141406 Efficient purification of adenovirus	Patent 7141406 was granted and assigned to GenVec on November, 2006 by the United States Patent and Trademark Office.		GenVec	United States Patent and Trademark Office	7141406	November 28, 2006
‌ US Patent 8920813 Adenoviral vector-based dengue fever vaccine	Patent 8920813 was granted and assigned to GenVec on December, 2014 by the United States Patent and Trademark Office.		GenVec	United States Patent and Trademark Office	8920813	December 30, 2014
‌ US Patent 10640776 Method for propagating adenoviral vectors encoding inhibitory gene products		GenVec	GenVec	United States Patent and Trademark Office	10640776	May 5, 2020

Results per page:

37 results

0 selected

37 results

0 selected